Placebo | VAS | OR* (VAS vs placebo) (95% CI) | |
---|---|---|---|
Proportion of monthly visits at which child was reported to have been ill in preceding 30 days | |||
Number of monthly visits completed | 26 571 | 27 465 | |
Fever | 8130/26 571 (31%) | 7928/27 465 (29%) | 0.94 (0.76 to 1.16)) p=0.5 |
Diarrhoea | 2609/26 571 (10%) | 2272/27 465 (8%) | 0.78 (0.57 to 1.08) p=0.1 |
Rapid breathing | 740/26 571 (2.8%) | 617/27 465 (2.3%) | 0.92 (0.55 to 1.53) p=0.7 |
Severe pneumonia | 245/26 571 (0.9%) | 121/27 465 (0.4%) | 0.42 (0.16 to 1.11) p=0.1 |
Data are n, n (%) or mean proportion of days with illness.
*OR estimated using Generalised Estimating Equation to account for cluster randomisation and adjusted for month of visit.
VAS, vitamin A supplementation.